Can You Take Famotidine with Voquezna (Vonoprazan)?
No, there is no contraindication to taking famotidine with vonoprazan (Voquezna), and combining an H2 receptor antagonist like famotidine with vonoprazan may provide additional nocturnal acid suppression when vonoprazan 10 mg alone is insufficient. 1
Rationale for Combination Therapy
Vonoprazan is a potassium-competitive acid blocker (P-CAB) that works through a completely different mechanism than famotidine, which is an H2 receptor antagonist—vonoprazan directly blocks the potassium-binding site of the proton pump, while famotidine blocks histamine receptors. 2
Research demonstrates that adding an H2RA to vonoprazan 10 mg can effectively prevent nocturnal acid breakthrough without further increasing serum gastrin levels, which is a theoretical concern with more potent acid suppression. 1
In a study of 13 healthy volunteers, combining vonoprazan 10 mg with lafutidine (an H2RA) achieved 100% pH 4 holding time at nighttime and reduced nocturnal acid breakthrough from 38% to 8%, while serum gastrin levels remained similar (323 pg/mL vs 420 pg/mL with vonoprazan alone). 1
Clinical Context for This Combination
This combination is most appropriate when vonoprazan 10 mg maintenance therapy provides inadequate nocturnal acid control, rather than immediately escalating to vonoprazan 20 mg, which causes higher gastrin elevation (504 pg/mL). 1
The American Gastroenterological Association recommends vonoprazan 10 mg for maintenance therapy in erosive esophagitis, making the addition of famotidine a logical step before dose escalation if breakthrough symptoms occur. 3
Important Caveat Regarding Tizanidine
If the patient is taking tizanidine (a muscle relaxant), famotidine should be used with extreme caution or avoided, as famotidine is a CYP1A2 inhibitor that can cause significant hypotension, bradycardia, and sedation when combined with tizanidine. 4
This drug interaction is specifically mentioned in perioperative guidelines as a significant concern, though it is unrelated to vonoprazan itself. 4
Safety Profile of the Combination
Both vonoprazan and famotidine are generally well-tolerated, with vonoprazan showing comparable short-term and medium-term safety to PPIs, with common adverse events including abdominal pain, constipation, diarrhea, nausea, and dyspepsia. 5, 6
No specific drug-drug interactions between vonoprazan and H2 receptor antagonists have been reported in clinical trials or safety analyses. 7